EMA Changes Azithromycin Use to Combat Antibiotic Resistance

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several changes to the way the antibiotic azithromycin is used in the EU, including the removal of certain indications.  The recommendations aim to optimize the use of the antibiotic and minimize the development of antimicrobial resistance…